UPDATE 1-Bristol-Myers tops forecasts, helped by Abilify royalty adjustment
April 28, 2015 at 07:55 AM EDT
April 28 (Reuters) - Bristol-Myers Squibb Co reported better-than- expected quarterly results, helped by cost cuts and a higher estimate of royalties owed the company from sales of its Abilify schizophrenia treatment.
